Ruurd Torensma
Nijmegen, GE 6500HB, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
ICAM3-Fc Outperforms Receptor-Specific Antibodies Targeted Nanoparticles to Dendritic Cells for Cross-Presentation.
Journal: Molecules (Basel, Switzerland)
Published: April 09, 2019
The Dilemma of Cure and Damage in Oligodendroglioma: Ways to Tip the Balance Away from the Damage.
Journal: Cancers
Published: October 09, 2018
Immune Curbing of Cancer Stem Cells by CTLs Directed to NANOG.
Journal: Frontiers in immunology
Published: April 06, 2018
Different Lipid Regulation in Ovarian Cancer: Inhibition of the Immune System.
Journal: International journal of molecular sciences
Published: December 22, 2017
Controlled release of antigen and Toll-like receptor ligands from PLGA nanoparticles enhances immunogenicity.
Journal: Nanomedicine (London, England)
Published: February 10, 2017
Umbilical cord blood CD34+ progenitor-derived NK cells efficiently kill ovarian cancer spheroids and intraperitoneal tumors in NOD/SCID/IL2Rgnull mice.
Journal: Oncoimmunology
Published: January 17, 2017
Isolation of Mononuclear Cell Populations from Ovarian Carcinoma Ascites.
Journal: Bio-protocol
Published: November 07, 2016
Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines.
Journal: Cancer research
Published: June 22, 2015
Humoral and cellular immune responses after influenza vaccination in patients with postcancer fatigue.
Journal: Human vaccines & immunotherapeutics
Published: May 22, 2015
Cellular immunotherapy in ovarian cancer: Targeting the stem of recurrence.
Journal: Gynecologic oncology
Published: December 09, 2014
Cord blood mesenchymal stem cells suppress DC-T Cell proliferation via prostaglandin B2.
Journal: Stem cells and development
Published: March 22, 2014
Last Updated: 09/26/2026